» Authors » Silvia Palombella

Silvia Palombella

Explore the profile of Silvia Palombella including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 133
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ragni E, De Luca P, Landoni S, Valli F, Mortati L, Palombella S, et al.
Regen Ther . 2024 Jul; 26:442-457. PMID: 39070124
Introduction: Extracellular vesicles from mesenchymal stromal cells (MSC-EVs) are potent stimulators of naïve cartilage and their injection is studied in clinical trials for cartilage lesions, since often cartilage repaired with...
2.
Brambilla S, Guiotto M, Torretta E, Armenia I, Moretti M, Gelfi C, et al.
Stem Cell Res Ther . 2023 Jul; 14(1):179. PMID: 37480149
Background: Trauma-associated peripheral nerve injury is a widespread clinical problem causing sensory and motor disabilities. Schwann cells (SCs) contribute to nerve regeneration, mainly by secreting nerve growth factor (NGF) and...
3.
Guiotto M, Palombella S, Brambilla S, Applegate L, Riehle M, Hart A, et al.
J Vis Exp . 2023 Feb; (192). PMID: 36806184
Considering the increasing impact of stem cell therapy, biosafety concerns have been raised regarding potential contamination or infection transmission due to the introduction of animal-derived products during in vitro manipulation....
4.
Bottagisio M, Palombella S, Lopa S, Sangalli F, Savadori P, Biagiotti M, et al.
Front Cell Infect Microbiol . 2023 Jan; 12:1056912. PMID: 36683682
Introduction: Implant-related infections and infected fractures are significant burdens in orthopedics. is one of the main causes of bone infections related to biofilm formation upon implants. Current antibiotic prophylaxis/therapy is...
5.
Palombella S, Perucca Orfei C, Castellini G, Gianola S, Lopa S, Mastrogiacomo M, et al.
Stem Cell Res Ther . 2022 Apr; 13(1):142. PMID: 35379348
Mesenchymal stem cell (MSC) culturing for cell therapies needs a step forward to be routinely used in clinical settings. Main concerns regard the use of animal origin reagents, in particular...
6.
Palombella S, Salehi S, Mondadori C, Talo G, Sansone V, Moretti M, et al.
Methods Mol Biol . 2021 Sep; 2373:253-266. PMID: 34520017
Microfluidics allows for recapitulating organotypic environments in miniaturized cell culture platforms. This ability paves the way to the investigation of complex biological processes in a relevant milieu. Here we describe...
7.
Mondadori C, Palombella S, Salehi S, Talo G, Visone R, Rasponi M, et al.
Biofabrication . 2021 Jun; 13(4). PMID: 34139683
The synovium of osteoarthritis (OA) patients can be characterized by an abnormal accumulation of macrophages originating from extravasated monocytes. Since targeting monocyte extravasation may represent a promising therapeutic strategy, our...
8.
Palombella S, Guiotto M, Higgins G, Applegate L, Raffoul W, Cherubino M, et al.
Stem Cell Res Ther . 2020 Oct; 11(1):432. PMID: 33023632
Background: The autologous nerve graft, despite its donor site morbidity and unpredictable functional recovery, continues to be the gold standard in peripheral nerve repair. Rodent research studies have shown promising...
9.
Ragni E, Palombella S, Lopa S, Talo G, Perucca Orfei C, De Luca P, et al.
Cells . 2020 May; 9(5). PMID: 32397409
Extracellular vesicles (EVs) showed therapeutic properties in several applications, many in regenerative medicine. A clear example is in the treatment of osteoarthritis (OA), where adipose-derived mesenchymal stem cells (ASCs)-EVs were...
10.
Palombella S, Lopa S, Gianola S, Zagra L, Moretti M, Lovati A
Stem Cells Int . 2020 Jan; 2019:3715964. PMID: 31949437
Nonunions represent one of the major indications for clinical settings with stem cell-based therapies. The objective of this research was to systematically assess the current evidence for the efficacy of...